Morgan Stanley
TDAC icon

Morgan Stanley’s Translational Development Acquisition Corp TDAC Stock Holding History

Morgan Stanley’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$663 Sell
62
-16
-21% -$171 ﹤0.01% 7579
2026
Q1 		$824 Buy
78
+20
+34% +$211 ﹤0.01% 7463
2025
Q4 		$607 Buy
58
+46
+383% +$479 ﹤0.01% 7472
2025
Q3 		$124 Sell
12
-49
-80% -$506 ﹤0.01% 7648
2025
Q2 		$626 Sell
61
-3,021
-98% -$30.7K ﹤0.01% 7402
2025
Q1 		$31.1K Buy
+3,082
New +$31K ﹤0.01% 6426

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Morgan Stanley's TDAC Position: Q2 2026 in Review

Morgan Stanley reduced its Translational Development Acquisition Corp (TDAC) stake by 21% in Q2 2026, selling an estimated $171 and leaving 62 shares worth $663. The position accounts for ﹤0.01% of the portfolio, ranked #7579.

Morgan Stanley first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $31.1K in Q1 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Morgan Stanley held 62 shares of Translational Development Acquisition Corp worth $663 as of Q2 2026.
  • Morgan Stanley sold 16 Translational Development Acquisition Corp shares in Q2 2026, an estimated $171.
  • Translational Development Acquisition Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7579 holding.
  • Morgan Stanley first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • Morgan Stanley's Translational Development Acquisition Corp position peaked at $31.1K in Q1 2025.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.